{{Rsnum
|rsid=1800443
|Gene=DRD4
|Chromosome=11
|position=639830
|Orientation=plus
|ReferenceAllele=T
|MissenseAllele=G
|GMAF=0.01194
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.7 | 12.9 | 86.4
| ASW | 0.0 | 15.8 | 84.2
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 6.4 | 93.6
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 2.6 | 97.4
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{omim
|desc=DOPAMINE RECEPTOR D4 POLYMORPHISM
|id=126452
|rsnum=1800443
|variant=0002
}}

{{ClinVar
|rsid=1800443
|Reversed=0
|FwdREF=T
|FwdALT=G
|REF=T
|ALT=G
|RSPOS=639830
|CHROM=11
|GMAF=0.0119
|dbSNPBuildID=89
|SSR=0
|SAO=1
|VP=0x050368000000150517110100
|GENEINFO=DRD4:1815
|GENE_NAME=DRD4
|GENE_ID=1815
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000011.9:g.639830T>G
|CLNORIGIN=1
|CLNSIG=2
|Tags=PM;PMC;S3D;SLO;VLD;G5;HD;GNO;KGPhase1;KGPROD;OTHERKG;PH3;LSD;OM
|CAF=0.9881; 0.01194
|CLNACC=RCV000018255.1
|CLNDBN=DOPAMINE RECEPTOR D4 POLYMORPHISM
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=126452.0002
|COMMON=1
|Disease=DOPAMINE RECEPTOR D4 POLYMORPHISM
}}

{{PMID Auto
|PMID=19584173
|Title=Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}